BHC
Price
$6.42
Change
+$0.08 (+1.26%)
Updated
Jul 15 closing price
Capitalization
3.86B
14 days until earnings call
BLCO
Price
$13.71
Change
+$0.04 (+0.29%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
6.07B
14 days until earnings call
Interact to see
Advertisement

BHC vs BLCO

Header iconBHC vs BLCO Comparison
Open Charts BHC vs BLCOBanner chart's image
Bausch Health Companies
Price$6.42
Change+$0.08 (+1.26%)
Volume$1.1M
Capitalization3.86B
Bausch + Lomb
Price$13.71
Change+$0.04 (+0.29%)
Volume$2.67K
Capitalization6.07B
BHC vs BLCO Comparison Chart in %
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. BLCO commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Hold and BLCO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (BHC: $6.42 vs. BLCO: $13.71)
Brand notoriety: BHC: Notable vs. BLCO: Not notable
BHC represents the Pharmaceuticals: Other, while BLCO is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BHC: 58% vs. BLCO: 43%
Market capitalization -- BHC: $3.86B vs. BLCO: $6.07B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. BLCO’s [@Medical Specialties] market capitalization is $6.07B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 0 FA rating(s) are green whileBLCO’s FA Score has 0 green FA rating(s).

  • BHC’s FA Score: 0 green, 5 red.
  • BLCO’s FA Score: 0 green, 5 red.
According to our system of comparison, BHC is a better buy in the long-term than BLCO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 5 TA indicator(s) are bullish while BLCO’s TA Score has 5 bullish TA indicator(s).

  • BHC’s TA Score: 5 bullish, 5 bearish.
  • BLCO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BLCO is a better buy in the short-term than BHC.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а -4.18% price change this week, while BLCO (@Medical Specialties) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +62.47%. For the same industry, the average monthly price growth was +4.88%, and the average quarterly price growth was +67.74%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was -1.40%.

Reported Earning Dates

BHC is expected to report earnings on Oct 30, 2025.

BLCO is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+62.47% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-1.00% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLCO($6.07B) has a higher market cap than BHC($3.86B). BLCO has higher P/E ratio than BHC: BLCO (909.09) vs BHC (13.39). BHC YTD gains are higher at: -20.347 vs. BLCO (-24.086). BHC has higher annual earnings (EBITDA): 2.2B vs. BLCO (499M). BHC has more cash in the bank: 947M vs. BLCO (331M). BLCO has less debt than BHC: BLCO (4.56B) vs BHC (22.4B). BHC has higher revenues than BLCO: BHC (8.76B) vs BLCO (4.15B).
BHCBLCOBHC / BLCO
Capitalization3.86B6.07B64%
EBITDA2.2B499M441%
Gain YTD-20.347-24.08684%
P/E Ratio13.39909.091%
Revenue8.76B4.15B211%
Total Cash947M331M286%
Total Debt22.4B4.56B491%
FUNDAMENTALS RATINGS
BHC: Fundamental Ratings
BHC
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BHCBLCO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
70%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 14 days ago
74%
Bullish Trend 6 days ago
65%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CNWEX87.310.17
+0.20%
American Funds New World 529E
NNTWX32.50N/A
N/A
Nicholas II N
EQIAX13.06N/A
N/A
Allspring Emerging Markets Eq Advtg A
TSRLX76.68N/A
N/A
Touchstone Large Cap Focused R6
TGVNX28.39-0.51
-1.76%
TCW Relative Value Mid Cap N